FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783256919> ?p ?o ?g. }

• W2783256919 endingPage "440" @default.
• W2783256919 startingPage "423" @default.
• W2783256919 abstract "Triple-negative breast cancer (TNBC), the most refractory subtype of breast cancer to current treatments, accounts disproportionately for the majority of breast cancer-related deaths. This is largely due to cancer plasticity and the development of cancer stem cells (CSCs). Recently, distinct yet interconvertible mesenchymal-like and epithelial-like states have been revealed in breast CSCs. Thus, strategies capable of simultaneously inhibiting bulk and CSC populations in both mesenchymal and epithelial states have yet to be developed. Wnt/β-catenin and Hippo/YAP pathways are crucial in tumorigenesis, but importantly also possess tumor suppressor functions in certain contexts. One possibility is that TNBC cells in epithelial or mesenchymal state may differently affect Wnt/β-catenin and Hippo/YAP signaling and CSC phenotypes. In this report, we found that YAP signaling and CD44high /CD24-/low CSCs were upregulated while Wnt/β-catenin signaling and ALDH+ CSCs were downregulated in mesenchymal-like TNBC cells, and vice versa in their epithelial-like counterparts. Dual knockdown of YAP and Wnt/β-catenin, but neither alone, was required for effective suppression of both CD44high /CD24-/low and ALDH+ CSC populations in mesenchymal and epithelial TNBC cells. These observations were confirmed with cultured tumor fragments prepared from patients with TNBC after treatment with Wnt inhibitor ICG-001 and YAP inhibitor simvastatin. In addition, a clinical database showed that decreased gene expression of Wnt and YAP was positively correlated with decreased ALDH and CD44 expression in patients' samples while increased patient survival. Furthermore, tumor growth of TNBC cells in either epithelial or mesenchymal state was retarded, and both CD44high /CD24-/low and ALDH+ CSC subpopulations were diminished in a human xenograft model after dual administration of ICG-001 and simvastatin. Tumorigenicity was also hampered after secondary transplantation. These data suggest a new therapeutic strategy for TNBC via dual Wnt and YAP inhibition." @default.
• W2783256919 created "2018-01-26" @default.
• W2783256919 creator A5007849592 @default.
• W2783256919 creator A5019124641 @default.
• W2783256919 creator A5020601988 @default.
• W2783256919 creator A5026085971 @default.
• W2783256919 creator A5027475930 @default.
• W2783256919 creator A5033047541 @default.
• W2783256919 creator A5041631891 @default.
• W2783256919 creator A5047155165 @default.
• W2783256919 creator A5047475750 @default.
• W2783256919 creator A5051175913 @default.
• W2783256919 creator A5056204035 @default.
• W2783256919 creator A5058218845 @default.
• W2783256919 creator A5061917666 @default.
• W2783256919 creator A5081766701 @default.
• W2783256919 creator A5084509310 @default.
• W2783256919 date "2018-02-21" @default.
• W2783256919 modified "2023-10-12" @default.
• W2783256919 title "Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states" @default.
• W2783256919 cites W1693243095 @default.
• W2783256919 cites W1866104439 @default.
• W2783256919 cites W1874478038 @default.
• W2783256919 cites W1964212105 @default.
• W2783256919 cites W1971085650 @default.
• W2783256919 cites W1974012180 @default.
• W2783256919 cites W1977291335 @default.
• W2783256919 cites W1995224853 @default.
• W2783256919 cites W1999519607 @default.
• W2783256919 cites W2004480757 @default.
• W2783256919 cites W2008202172 @default.
• W2783256919 cites W2026580699 @default.
• W2783256919 cites W2027150010 @default.
• W2783256919 cites W2034428193 @default.
• W2783256919 cites W2042965279 @default.
• W2783256919 cites W2069264443 @default.
• W2783256919 cites W2085039090 @default.
• W2783256919 cites W2094187675 @default.
• W2783256919 cites W2096283457 @default.
• W2783256919 cites W2105504936 @default.
• W2783256919 cites W2107931058 @default.
• W2783256919 cites W2114843025 @default.
• W2783256919 cites W2118258530 @default.
• W2783256919 cites W2119362105 @default.
• W2783256919 cites W2121516377 @default.
• W2783256919 cites W2130100751 @default.
• W2783256919 cites W2136859326 @default.
• W2783256919 cites W2139160260 @default.
• W2783256919 cites W2145357526 @default.
• W2783256919 cites W2148056172 @default.
• W2783256919 cites W2148294117 @default.
• W2783256919 cites W2149441684 @default.
• W2783256919 cites W2150163671 @default.
• W2783256919 cites W2155756738 @default.
• W2783256919 cites W2159640574 @default.
• W2783256919 cites W2162579298 @default.
• W2783256919 cites W2165286055 @default.
• W2783256919 cites W2221752800 @default.
• W2783256919 cites W2235523093 @default.
• W2783256919 cites W2286612125 @default.
• W2783256919 cites W2292593918 @default.
• W2783256919 cites W2296320058 @default.
• W2783256919 cites W2330249153 @default.
• W2783256919 cites W2341467683 @default.
• W2783256919 cites W2375577403 @default.
• W2783256919 cites W2512182078 @default.
• W2783256919 cites W2550669964 @default.
• W2783256919 cites W2556760701 @default.
• W2783256919 cites W2735513607 @default.
• W2783256919 cites W2747280021 @default.
• W2783256919 cites W4238567307 @default.
• W2783256919 doi "https://doi.org/10.1002/1878-0261.12167" @default.
• W2783256919 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5891054" @default.
• W2783256919 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29316250" @default.
• W2783256919 hasPublicationYear "2018" @default.
• W2783256919 type Work @default.
• W2783256919 sameAs 2783256919 @default.
• W2783256919 citedByCount "51" @default.
• W2783256919 countsByYear W27832569192018 @default.
• W2783256919 countsByYear W27832569192019 @default.
• W2783256919 countsByYear W27832569192020 @default.
• W2783256919 countsByYear W27832569192021 @default.
• W2783256919 countsByYear W27832569192022 @default.
• W2783256919 countsByYear W27832569192023 @default.
• W2783256919 crossrefType "journal-article" @default.
• W2783256919 hasAuthorship W2783256919A5007849592 @default.
• W2783256919 hasAuthorship W2783256919A5019124641 @default.
• W2783256919 hasAuthorship W2783256919A5020601988 @default.
• W2783256919 hasAuthorship W2783256919A5026085971 @default.
• W2783256919 hasAuthorship W2783256919A5027475930 @default.
• W2783256919 hasAuthorship W2783256919A5033047541 @default.
• W2783256919 hasAuthorship W2783256919A5041631891 @default.
• W2783256919 hasAuthorship W2783256919A5047155165 @default.
• W2783256919 hasAuthorship W2783256919A5047475750 @default.
• W2783256919 hasAuthorship W2783256919A5051175913 @default.
• W2783256919 hasAuthorship W2783256919A5056204035 @default.
• W2783256919 hasAuthorship W2783256919A5058218845 @default.
• W2783256919 hasAuthorship W2783256919A5061917666 @default.

• next